| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
CMO | Chief Medical Officer
2 companies
Rosenberg Noah L. is a Chief Medical Officer at Travere Therapeutics, Inc. with holdings across 2 companies. Recent SEC Form 4 filings include 0 buys and 4 sells.
Estimated insider holdings value: $2.0M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| May 12, 2020 | TVTX Travere Therapeutics, Inc. | Chief Medical Officer | Sell | 527 | $16.98 | $8,950.73 | -1.9% | |
| Mar 5, 2020 | TVTX Travere Therapeutics, Inc. | Chief Medical Officer | Sell | 1,790 | $15.36 | $27,487.24 | -6.2% | |
| Jul 31, 2019 | TVTX Travere Therapeutics, Inc. | Chief Medical Officer | Sell | 2,500 | $19.95 | $49,862.50 | -8.1% |